Beyond antibiotics: probiotics as a promising ally against Helicobacter pylori
Helicobacter pylori (H. pylori) is considered a key causative agent of gastritis, peptic ulcer, and gastric cancer, affecting more than half of the world’s population. The eradication rate of antibiotic therapy gradually decreases due to the increased risk of resistance. Recent studies have shown th...
Saved in:
| Main Authors: | Lin Yuan, Chong Yang, Ying Han, Fan Yang, Huabing Tu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1620870/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Can probiotics improve efficiency and safety profile of triple Helicobacter pylori eradication therapy? A prospective randomized study
by: Grgov Saša, et al.
Published: (2016-01-01) -
Treatment of Helicobacter Pylori – an Overview of Current Strategies of Diagnostic and Treatment
by: Ruxandra BABIUC, et al.
Published: (2021-09-01) -
New Approaches to Therapy of Helicobacter pylori Infection (by the Materials of the Maastricht Consensus-IV, Florence, 2010)
by: A. G. Evdokimova, et al.
Published: (2020-05-01) -
Benefits of Helicobacter pylori Eradication on Extragastric Diseases
by: Tae Jun Kim, et al.
Published: (2021-12-01) -
Helicobacter pylori associated with chronic urticaria
by: Lobna Ben Mahmoud, et al.
Published: (2011-07-01)